Implementation and Patient-Reported Outcomes of an Insurance-Supported Integrative Oncology Symptom Management Program [0.03%]
一种综合肿瘤症状管理模式的实施和患者报告结果：保险公司支持项目经验报告
Meha Srivastava,Samuel N Rodgers-Melnick,Jacob Wolf et al.
Meha Srivastava et al.
Purpose: While integrative oncology (IO) modalities are recommended for symptom management, few models describe guideline-supported or sustainable care. This study (1) describes the initial implementation of a hybrid insu...
Implementing Systems-Based Interventions to Improve the Care of Cancer Survivors: Small Steps, Large Challenges [0.03%]
基于系统的干预措施改善癌症幸存者护理的实施：小步骤，大挑战
Steven J Atlas,Larissa Nekhlyudov
Steven J Atlas
Patient Engagement With an Electronic Patient-Reported Outcomes Tool Evaluating Hospital Discharge Readiness After Cancer Surgery [0.03%]
电子患者报告结果工具评估癌症手术后出院准备情况患者的参与度
Jennifer R Cracchiolo,Richard S Matulewicz,Norma E Farrow et al.
Jennifer R Cracchiolo et al.
Purpose: Patients undergoing cancer surgery often face complex, multidisciplinary needs related to recovery and discharge. The aim of this study was to develop and assess the adoption of an electronic patient-reported out...
Access Challenges in Allogeneic Hematopoietic Cell Transplant: Identifying At-Risk US States by Exploring Social Vulnerability, Physician Density, and Unmet Need [0.03%]
同种异体造血细胞移植的准入挑战：通过探索社会脆弱性、医生密度和未满足需求来识别有风险的美国各州
Samantha E Watters,Christa L Meyer,Jaime M Preussler et al.
Samantha E Watters et al.
Purpose: Access to allogeneic hematopoietic cell transplantation (alloHCT) is limited by factors beyond physician control. A more complete picture of how barriers to alloHCT overlap is needed to target access-related init...
Getting It Right the First Time: Improving Antibiotic Stewardship in Febrile Oncology Patients Presenting to the Pediatric Emergency Department [0.03%]
首次就做好抗生素 stewardship 的改善：发热性肿瘤患儿到儿科急诊部门 presenting 抗生素
Leslie Hueschen,Chris Kaberline,Stephanie Clark et al.
Leslie Hueschen et al.
Purpose: Febrile pediatric oncology patients with central lines are at high risk of sepsis. However, emerging evidence fails to support the historic 1-hour window for antibiotic administration in well-appearing patients, ...
Current Roles of Neoadjuvant and Perioperative Immunotherapy in Non-Small Cell Lung Cancer [0.03%]
新辅助和围手术期免疫治疗在非小细胞肺癌中的作用
Olivia Fankuchen,Salman Punekar,Vamsidhar Velcheti
Olivia Fankuchen
Immune checkpoint inhibitors (ICIs) in non-small cell lung cancer (NSCLC) have improved survival for patients with early-stage NSCLC who are candidates for surgical resection. ICIs enhance antitumor responses and improve a variety of periop...
Impact of Graft-Versus-Host Disease Prophylaxis on Long-Term Outcomes in Patients Surviving Beyond Two Years After Allogeneic Transplantation [0.03%]
同种异体移植后存活两年以上的患者移植物抗宿主病预防对长期结局的影响
Nihar Desai,Sergio Rodriguez-Rodriguez,Carol Chen et al.
Nihar Desai et al.
Purpose: Post-transplant cyclophosphamide (PTCy) is increasingly used for graft-versus-host disease (GVHD) prophylaxis, but long-term outcomes remain incompletely defined. ...
Timing Is Not Everything: Reassessing Chrono-Immunotherapy in Clinical Practice [0.03%]
时机并非一切：临床实践中重新评估chrono免疫疗法
Reid Shaw,Daniel J Olson
Reid Shaw
Survival Outcomes in Breast Cancer Patients With Use of Vaginal Estrogen Therapy: A SEER Analysis [0.03%]
阴道雌激素治疗乳腺癌患者的生存结局：基于SEER数据库的分析研究
Olivia R Mitchel,Chiu-Hsieh Paul Hsu,Leah S Millheiser et al.
Olivia R Mitchel et al.
Purpose: Antihormonal therapy, including tamoxifen or aromatase inhibitors, is central to the treatment of hormone receptor-positive breast cancers. A common adverse effect is genitourinary syndrome of menopause, which ma...
James M Isaacs
James M Isaacs